A password is required to submit a request for an internal transfer. In order to obtain the password you can check any of the following resources: Login to the employee portal, check the current issue of "Regional High Points" newsletter, contact HR, or read this week's "Daily Announcements".
Breast cancer is a disease in which cancer cells grow in the breast tissue. It is the most common cancer in women in the United States. The normal breast consists of glandular tissue called lobes. These lobes are sectioned off into lobules, which produce milk. Milk is carried to from the lobules to the nipple by small ducts. All this tissue is surrounded by fatty and connective tissue, as well as blood and lymph vessels.
Types of breast cancer found in women are:
Ductal carcinoma situ—Early stage cancer confined to the ducts. This type has a high cure rate.
Lobular carcinoma in situ (LCIS)—Most doctors consider the finding of LCIS to be incidental, and it is thought to be a marker for breast cancer risk. Women with LCIS seem to have a 7-10 times increased risk of developing some form of breast cancer (usually infiltrating lobular carcinoma) over the next 20 years.
Infiltrating ductal carcinoma—A cancer that starts in the ducts of the breast and spreads into surrounding tissues.
This is the most common type of breast cancer in women.
Infiltrating lobular carcinoma—A cancer that starts in the lobules of the breast and spreads into surrounding tissues.
Medullary, mucinous, and tubular carcinomas—These are three relatively slower-growing types of breast cancer.
Inflammatory carcinoma—A rare and aggressive form of breast cancer that can be difficult to treat. This cancer invades the lymphatic vessels of the skin and can be very extensive. It is very likely to spread to the local lymph nodes.
Paget's disease—A very rare cancer of the areola and nipple. Although Paget's does not arise from glandular tissue in the breast, it can be associated with both in situ and infiltrating breast cancers.
Cancer occurs when cells in the body divide without control or order. Eventually these uncontrolled cells form a growth or tumor. The term cancer refers to malignant growths. These growths can invade nearby tissues including the lymph nodes. Cancer that has invaded the lymph nodes can then spread to other parts of the body. The lymph nodes associated with breast cancer are in the armpit, above the collarbone, and in the chest.
It is not clear exactly what causes these problems in the cells, but is probably a combination of genetics and environment.
Your doctor may need to test your breast tissue and adjacent lymph nodes. A sample will be removed and sent to a lab to look for cancer cells. This can be done with different biopsy types, including:
aspiration—Removal of fluid and/or cells from a breast lump using a thin needle.
Needle biopsy—Removal of tissue with a needle from an area that looks unusual on a mammogram but cannot be felt.
Incisional biopsy—Cutting out a sample of a lump or suspicious area.
Excisional biopsy—Cutting out all of a lump or suspicious area and an area of healthy tissue around the edges.
If cancer is present, your doctor may order tests to learn about the type of cancer. These may include:
Blood tests—To look for tumor markers or genetic mutations.
Tissue evaluation—To look for estrogen and progesterone receptors, and the presence of HER2/neu and Oncotype DX. These are used to help plan therapy.
The physical exam combined with all of your test results, will help to determine the stage of cancer you have. Staging is used to guide your treatment plan. Like other cancers, breast cancer is staged from I-IV. Stage I is a very localized cancer, while stage IV indicates a spread to other parts of the body.
Cancer treatment varies depending on the stage and type of cancer.
A combination of therapies is most effective. For example, radiation may be used before surgery to shrink the tumor or after to make sure all the cancer has been removed.
Treatment options include:
The goal of surgery is to remove the tumors and any affected tissue.
Lumpectomy—Removal of the breast cancer and some normal tissue around it. Often, some of the lymph nodes under the arm are also removed.
This may also be called tylectomy or quadrantectomy.
Segmentectomy—Removal of the cancer and a larger area of normal breast tissue around it.
Simple mastectomy—Removal of the breast, or as much of the breast as possible. If the surgeon removes some lymph nodes for biopsy, it is done with a separate incision. This is the most common surgery for breast cancer treatment.
Skin-sparing mastectomy—The same amount of tissue is removed as with a simple mastectomy, but the skin over the breast is spared. This can be used when immediate breast reconstruction surgery is planned. A variation of this procedure also can spare the nipple and areola. This may not be an option for all women.
Modified radical mastectomy—Removal of the whole breast, the lymph nodes under the arm and, often, the lining over the chest muscles.
Radical mastectomy—Removal of the breast, both chest muscles, the lymph nodes under the arm, and some additional fat and skin. This procedure is only considered in rare cases. It is done if the cancer has spread to the chest muscles.
Sentinel lymph node biopsy—A small amount of blue dye and/or a radioactive tracer is placed in the area where the tumor was located. The lymph nodes that pick up the substance are removed. Those remaining lymph nodes should be removed if any sentinel nodes contain cancer. This method is usually done in women who do not have lymph nodes that can be felt in the armpit.
Axillary lymph node dissection—Removal of the lymph nodes under the arm. This is done to help determine whether cancer cells have entered the lymphatic system.
Cryotherapy—Extreme cold is used to freeze and destroy cancer cells. Cryotherapy is considered to be experimental at this time.
Radiation therapy is the use of radiation to kill cancer cells and shrink tumors. The main types of radiation include:
External radiation therapy—Radiation directed at the breast from a source outside the body.
Internal radiation therapy—Radioactive materials are placed into the breast in or near the cancer cells.
Microwave thermotherapy—Used to bring cancer cells to a high temperature. This may make them more sensitive to when exposed to traditional radiation therapy treatment. It is early in the research process and may not be available in all areas.
is the use of drugs to kill cancer cells. It may be given in many forms including pill, injection, or IV. The drugs enter the bloodstream. They travel through the body killing mostly cancer cells. Some healthy cells are killed as well.
The following therapies may be used in conjunction with chemotherapy:
Biologic therapy —The use of medications or substances made by the body to treat cancer. Biologic response modifier (BRM) therapy is the use of medications to increase or restore the body's natural defenses against cancer.
Targeted therapy —Treats specific characteristics of cancer cells by altering how the body responds to them. For example, medications can block the growth of new blood vessels or block chemical signals that allow cancer cells to grow and function.
Hormone blocking therapy —Designed to take advantage of the fact that many breast cancers are estrogen sensitive. Estrogen binds to the estrogen-sensitive cells and stimulates them to grow and divide. Anti-estrogen drugs prevent the binding of estrogen. This stops the cells from growing and prevents or delays breast cancer from returning.
Finding breast cancer early and treating it is the best way to prevent death from the disease. Breast cancer does not cause symptoms in the early stages. It is important to have screening exams and tests. These steps can help to find the cancer before symptoms appear. The following recommendations are for women with no symptoms who are not high risk for breast cancer:
Age 40-49—Recommendations vary from waiting until age 50 to having the screening every 1-2 years.
Age 50-74—Ranges from every year to every two years.
Clinical breast exam:
Age 20-39—Ranges from every year to every three years.
Age 40 and older—Every year.
is optional for those age 20 and older. Talk to your doctor about the risks and benefits.
If you have an increased risk of breast cancer, you may need to start having mammograms earlier. You and your doctor can decide on the best screening schedule for you. It is important to note that mammograms are the most sensitive test currently used to evaluate the breast, but they will miss 10-15% of breast cancers. Mammograms also have a false positive result about 33% of the time. A false positive result occurs when a test suggests an illness that actually does not exist.
There are two medications to prevent breast cancer in high-risk, postmenopausal women. These medications increase your chances of having blood clots and stroke. Talk to your doctor about whether medication is right for you.
If you are at very high risk for breast cancer, surgery to remove your breasts before you get cancer (a procedure called prophylactic
mastectomy) may be an option.
Breast cancer. American Cancer Society website. Available at: ...(Click grey area to select URL) Accessed December 31, 2013.
Breast cancer. National Cancer Institute website. Available at: ...(Click grey area to select URL) Accessed December 31, 2013.
Breast cancer in women. EBSCO DynaMed website. Available at: ...(Click grey area to select URL) Updated December 16, 2013. Accessed December 31, 2013.
Cryotherapy. Breast Cancer website. Available at: ...(Click grey area to select URL) Updated September 17, 2013. Accessed December 31, 2013.
How radiation works. Breast Cancer website. Available at: ...(Click grey area to select URL) Updated November 20, 2012. Accessed December 31, 2013.
12/21/2006 DynaMed's Systematic Literature Surveillance ...(Click grey area to select URL) Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L; Trial Management Group. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial. Lancet. 2006;368:2053-2060.
1/19/2010 DynaMed's Systematic Literature Surveillance ...(Click grey area to select URL) Lee C, Dershaw D, Kopans D, et al. Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. J Am Coll Radiol. 2010;7(1):18.
1/28/2011 DynaMed's Systematic Literature Surveillance ...(Click grey area to select URL) Lostumbo L, Carbine N, Wallace J. Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev. 2010;(11):CD002748.
9/26/2013 DynaMed's Systematic Literature Surveillance ...(Click grey area to select URL) Herman A. USPSTF updates to guidelines on using medications to prevent breast cancer. NEJM Journal Watch. 2013 Sept 24. Available at: http://www.jwatch.org/fw107927/2013/09/24/uspstf-updates-guidelines-using-medications-prevent?query=pfw. Published September 24, 2013. Accessed December 31, 2013.
10/1/2013 DynaMed's Systematic Literature Surveillance ...(Click grey area to select URL) Hughes KS, Schnaper LA, Bellon JR, et al. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol. 2013 Jul 1;31(19):2382-7.
6/24/2014 DynaMed's Systematic Literature Surveillance ...(Click grey area to select URL) Farvid MS, Cho E, et al. Dietary protein sources in early adulthoood and breast cancer incidence: prospective cohort study. BMJ. 2014 Jun 10;348:g3437.
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.